The Department of Chemical and Biological Enginnering is delighted to host the 28th Annual Hulburt Lecture, which will be presented by ChBE advisory board member, Joan Stafslien. Date & Time: Thursday, May 12th 9:00 am - 10:00 amLocation: Ford ITW Room (refreshments will be available at 8:45am)*** All ChBE Faculty, Graduate Students and Staff are also invitedto lunch at Performance Hall (2122 Sheridan Road, entrance door on Haven St.) at 12:00pm Speaker: Joan Stafslien, Former EVP, General Counsel & Corporate Secretary at CareFusionTitle: Challenge for Healthcare: Effective & Safe Medication Delivery AbstractIn this talk, we will discuss the challenges the healthcare system faces in meeting its mission of healing the sick while at the same time "doing no harm." In the seminal 1999 report, "To Err is Human," the Institute of Medicine calls medical errors "the nation's epidemic." In particular, we will focus on the complexities of delivering medications to patients effectively and safely in the hospital setting, where patients receive the most lifesaving (and, paradoxically, the most toxic) drugs. While manufacturers excel at creating the chemical or biologic drug, 1 in 5 medical injuries is caused by a medication error. We will explore why, how and where medication errors occur in acute care hospitals. We will also explore some of the advances that have been made to ensure patients are not harmed. BioJoan Stafslien has over 22 years of executive experience in the life science industry. As CareFusion's General Counsel and corporate secretary, Ms. Stafslien led the legal team in the spin-off from Cardinal Health in 2009. From 2009-2015, she was a member of the Executive Leadership Team that successfully built CareFusion into a leading medical technology company. In 2014-15, Ms. Stafslien led the legal team in the acquisition of CareFusion by Becton, Dickinson & Company for $12.6 billion. Prior to CareFusion, Ms. Stafslien was Segment General Counsel of Cardinal Health's medical device segment, which would become CareFusion through the spin-off, and Deputy General Counsel of Alaris Medical Systems. Prior to Alaris, Ms. Stafslien was in private practice with Brobeck, Phleger & Harrison. Ms. Stafslien also worked for Dow Chemical Company in chemical sales and engineering. Ms. Stafslien holds a JD from University of Wisconsin Law School, cum laude, and a BS (Chemical Engineering) from Northwestern University, Tau Beta Pi. She is on the advisory board of the Chemical and Biological Engineering Department. She also is a board member of a private k-12 college prep school and a non-profit supporting organ transplant.